相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Materials for Immunotherapy
C. Wyatt Shields et al.
ADVANCED MATERIALS (2020)
Smart Injectable Hydrogels for Cancer Immunotherapy
Yu Chao et al.
ADVANCED FUNCTIONAL MATERIALS (2020)
Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma
Shailender Bhatia et al.
CLINICAL CANCER RESEARCH (2020)
Immunogenicity Risk Assessment for PEGylated Therapeutics
Johanna R. Mora et al.
AAPS JOURNAL (2020)
Advanced biomaterials for cancer immunotherapy
Fan Yang et al.
ACTA PHARMACOLOGICA SINICA (2020)
Layer-by-Layer Biomaterials for Drug Delivery
Dahlia Alkekhia et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 22 (2020)
Bioresponsive microspheres for on-demand delivery of anti-inflammatory cytokines for articular cartilage repair
Eunjae Park et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2020)
Randomized Phase III Study of FOLFOX Alone and with Pegilodecakin as Second-line Therapy in Patients with Metastatic Pancreatic Cancer (SEQUOIA).
J. Randolph Hecht et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The entry of nanoparticles into solid tumours
Shrey Sindhwani et al.
NATURE MATERIALS (2020)
Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy
Meenu Sharma et al.
NATURE COMMUNICATIONS (2020)
Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar!
Nina Bono et al.
PHARMACEUTICS (2020)
The Importance of Poly(ethylene glycol) Alternatives for Overcoming PEG Immunogenicity in Drug Delivery and Bioconjugation
Thai Thanh Hoang Thi et al.
POLYMERS (2020)
Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2
Richard K. Yang et al.
CLINICAL CANCER RESEARCH (2020)
Rationale for IL-15 superagonists in cancer immunotherapy
Karin M. Knudson et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2020)
Cytokine-Encapsulated Biodegradable Microspheres for Immune Therapy
Nejat K. Egilmez
IMMUNOLOGICAL INVESTIGATIONS (2020)
Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02)
Adi Diab et al.
CANCER DISCOVERY (2020)
Cellular backpacks for macrophage immunotherapy
C. Wyatt Shields et al.
SCIENCE ADVANCES (2020)
Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist
Karin M. Knudson et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy
Jared E. Lopes et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells
Andreas A. Hombach et al.
CELLS (2020)
Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours
Aslan Mansurov et al.
NATURE BIOMEDICAL ENGINEERING (2020)
Cancer Cell Coating Nanoparticles for Optimal Tumor-Specific Cytokine Delivery
Antonio E. Barberio et al.
ACS NANO (2020)
A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4+CD25+FOXP3+Tregs that inhibit experimental autoimmune encephalomyelitis (EAE)
Cody D. Moorman et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Enhancing cancer immunotherapy with nanomedicine
Darrell J. Irvine et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Human and murine IL2 receptors differentially respond to the human-IL2 component of immunocytokines
Zulmarie Perez Horta et al.
ONCOIMMUNOLOGY (2019)
Antibody-cytokine fusion proteins: Biopharmaceuticals with immunomodulatory properties for cancer therapy
Cornelia Hutmacher et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Oncolytic adenoviruses: a game changer approach in the battle between cancer and the immune system.
Victor Cervera-Carrascon et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2019)
Development of an Interleukin-12 Fusion Protein That Is Activated by Cleavage with Matrix Metalloproteinase 9
Denise Skrombolas et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)
Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma
John D. Heiss et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2019)
Second-generation IL-2 receptor-targeted diphtheria fusion toxin exhibits antitumor activity and synergy with anti-PD-1 in melanoma
Laurene S. Cheung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs
Susannah L. Hewitt et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Antibody-Cytokine Fusions: Versatile Products for the Modulation of Anticancer Immunity
Dario Neri
CANCER IMMUNOLOGY RESEARCH (2019)
Order of administration of combination cytokine therapies can decouple toxicity from efficacy in syngeneic mouse tumor models
Adrienne Rothschilds et al.
ONCOIMMUNOLOGY (2019)
Advances in immunotherapy delivery from implantable and injectable biomaterials
David G. Leach et al.
ACTA BIOMATERIALIA (2019)
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma
Andres J. M. Ferreri et al.
BLOOD (2019)
Prolonged PSA stabilization and overall survival following sipuleucel-T monotherapy in metastatic castration-resistant prostate cancer patients
Eda K. Holl et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2019)
Targeted antibody and cytokine cancer immunotherapies through collagen affinity
Jun Ishihara et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel 1L2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors
Salah-Eddine Bentebibel et al.
CANCER DISCOVERY (2019)
Macroscale biomaterials strategies for local immunomodulation
Maxence O. Dellacherie et al.
NATURE REVIEWS MATERIALS (2019)
Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy
Noor Momin et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Neo-DREAM study investigating Daromun for the treatment of clinical stage IIIB/C melanoma
John T. Miura et al.
FUTURE ONCOLOGY (2019)
The Role of TRAIL/DRs in the Modulation of Immune Cells and Responses
Duygu Sag et al.
CANCERS (2019)
14P Anti-PDL1/IL-15 fusion protein increases rare effector cells in cynomolgus monkeys and mice
S Martomo et al.
ANNALS OF ONCOLOGY (2019)
Bempegaldesleukin (NKTR-214): a CD-122-biased IL-2 receptor agonist for cancer immunotherapy
Stephen K. Doberstein
EXPERT OPINION ON BIOLOGICAL THERAPY (2019)
Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers
Zongmin Zhao et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment
Bradley N. Mills et al.
CELL REPORTS (2019)
Cytokines in clinical cancer immunotherapy
Pedro Berraondo et al.
BRITISH JOURNAL OF CANCER (2019)
Albumin fusion improves the pharmacokinetics and in vivo antitumor efficacy of canine interferon gamma
Bing Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Delivery technologies for cancer immunotherapy
Rachel S. Riley et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Double-slit photoelectron interference in strong-field ionization of the neon dimer
Maksim Kunitski et al.
NATURE COMMUNICATIONS (2019)
First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors
Julius Strauss et al.
CLINICAL CANCER RESEARCH (2019)
Improving cancer immunotherapy through nanotechnology
Michael S. Goldberg
NATURE REVIEWS CANCER (2019)
Nanoparticles in the clinic: An update
Aaron C. Anselmo et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2019)
Clinical Activity and Tolerability of SL-401 (Tagraxofusp): Recombinant Diphtheria Toxin and Interleukin-3 in Hematologic Malignancies
Omar Alkharabsheh et al.
BIOMEDICINES (2019)
Recent advances in the development of gene delivery systems
Y. K. Sung et al.
BIOMATERIALS RESEARCH (2019)
Immunochemotherapy mediated by thermosponge nanoparticles for synergistic anti-tumor effects
Yongdan Zhao et al.
JOURNAL OF CONTROLLED RELEASE (2018)
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
John M. Wrangle et al.
LANCET ONCOLOGY (2018)
NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3
Vanesa Gregorc et al.
LANCET ONCOLOGY (2018)
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
Li Tang et al.
NATURE BIOTECHNOLOGY (2018)
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
Jonathan T. Sockolosky et al.
SCIENCE (2018)
Structural absorption by barbule microstructures of super black bird of paradise feathers
Dakota E. McCoy et al.
NATURE COMMUNICATIONS (2018)
Interferon β for Multiple Sclerosis
Dejan Jakimovski et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging
Silvia Franze et al.
PHARMACEUTICS (2018)
Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)
A. Marabelle et al.
ANNALS OF ONCOLOGY (2018)
PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients
Aung Naing et al.
CANCER CELL (2018)
DOX/IL-2/IFN-γ co-loaded thermo-sensitive polypeptide hydrogel for efficient melanoma treatment
Qiang Lv et al.
BIOACTIVE MATERIALS (2018)
From supernatants to cytokines: a personal view on the early history of IL-1, IL-1Ra, TNF and its inhibitor in rheumatology
Jean-Michel Dayer
ARTHRITIS RESEARCH & THERAPY (2018)
Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer
Sean G. Smith et al.
ONCOIMMUNOLOGY (2017)
Immunotoxins in cancer therapy: Review and update
Bahman Akbari et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2017)
Polymer therapeutics and the EPR effect
Hiroshi Maeda
JOURNAL OF DRUG TARGETING (2017)
Tumor-related interleukins: old validated targets for new anti-cancer drug development
Sarra Setrerrahmane et al.
MOLECULAR CANCER (2017)
Potent antitumour activity of interleukin-2-Fc fusion proteins requires Fc-mediated depletion of regulatory T-cells
Rodrigo Vazquez-Lombardi et al.
NATURE COMMUNICATIONS (2017)
Cergutuzumab amunaleukin (CEA-IL2v), a CEA- targeted IL-2 variant- based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines
Christian Klein et al.
ONCOIMMUNOLOGY (2017)
Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapy
Deborah Charych et al.
PLOS ONE (2017)
Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment
Yi Wang et al.
BIOMATERIALS (2017)
Interleukin-2 as an adjunct to antiretroviral therapy for HIV-positive adults
Jennifer Onwumeh et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
A Phase III Study of Balugrastim Versus Pegfilgrastim in Breast Cancer Patients Receiving Chemotherapy With Doxorubicin and Docetaxel
Oleg Gladkov et al.
ONCOLOGIST (2016)
Development of a long-acting, protein-loaded, redox-active, injectable gel formed by a polyion complex for local protein therapeutics
Shiro Ishii et al.
BIOMATERIALS (2016)
NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models
Deborah H. Charych et al.
CLINICAL CANCER RESEARCH (2016)
The role of IL-29 in immunity and cancer
Noah E. Kelm et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Immunocytokines for cancer treatment: past, present and future
Dario Neri et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Immunocytokines: a novel class of products for the treatment of chronic inflammation and autoimmune conditions
Franziska Bootz et al.
DRUG DISCOVERY TODAY (2016)
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
Kelly D. Moynihan et al.
NATURE MEDICINE (2016)
Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease
Jing Liu et al.
CANCER DISCOVERY (2016)
Designing hydrogels for controlled drug delivery
Jianyu Li et al.
NATURE REVIEWS MATERIALS (2016)
Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy
Hasan Rehman et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Antibody-interferon-alpha fusion protein (IGN002) for the treatment of b-cell non-Hodgkin lymphomas: A phase 1, first-in-human, dose-escalation trial
Patricia Ann Young et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Nanoparticles in the clinic
Aaron C. Anselmo et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2016)
Paracrine co-delivery of TGF-beta and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells
Michael D. McHugh et al.
BIOMATERIALS (2015)
Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2
Eric F. Zhu et al.
CANCER CELL (2015)
Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer
Sean G. Smith et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Monocyte-mediated delivery of polymeric backpacks to inflamed tissues: a generalized strategy to deliver drugs to treat inflammation
Aaron C. Anselmo et al.
JOURNAL OF CONTROLLED RELEASE (2015)
The Role of Cytokines in Breast Cancer Development and Progression
Marcela Esquivel-Velazquez et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Formulation and Stability of Cytokine Therapeutics
Tiina Lipiainen et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution
Alice Tzeng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Anti-PEG immunity: emergence, characteristics, and unaddressed questions
Qi Yang et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2015)
Injectable cryogel-based whole-cell cancer vaccines
Sidi A. Bencherif et al.
NATURE COMMUNICATIONS (2015)
Biopolymer implants enhance the efficacy of adoptive T-cell therapy
Sirkka B. Stephan et al.
NATURE BIOTECHNOLOGY (2015)
Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy
Jaeyun Kim et al.
NATURE BIOTECHNOLOGY (2015)
Remission Induction in a Phase I/II Study of an Anti-CD20-Interleukin-2 Immunocytokine DI-Leu16-IL2 in Patients with Relapsed B-Cell Lymphoma
Veronika Bachanova et al.
BLOOD (2015)
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
Mark D. Turner et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
Interleukin 12: still a promising candidate for tumor immunotherapy?
Witold Lasek et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Challenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy
Denise Skrombolas et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2014)
Low-Dose Interleukin-2 Therapy: A Driver of an Imbalance between Immune Tolerance and Autoimmunity
Agata Kosmaczewska
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Targeted modified IL-2 (NHS-IL2, MSB0010445) combined with stereotactic body radiation in advanced melanoma patients after progression on ipilimumab: Assessment of safety, clinical, and biologic activity in a phase 2a study
Howard L. Kaufman et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Interleukin-2 in Renal Cell Carcinoma: A Has-Been or a Still-Viable Option?
Asim Amin et al.
JOURNAL OF KIDNEY CANCER AND VHL (2014)
Peptide-Mediated Targeting of Cytokines to Tumor Vasculature: The NGR-hTNF Example
Angelo Corti et al.
BIODRUGS (2013)
Role of chitosan co-formulation in enhancing interleukin-12 delivery and antitumor activity
Lirong Yang et al.
BIOMATERIALS (2013)
Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting Treg
Andreas S. Baur et al.
BLOOD (2013)
Localized Immunotherapy via Liposome-Anchored Anti-CD137+IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
Brandon Kwong et al.
CANCER RESEARCH (2013)
A new platform for constructing antibody-cytokine fusion proteins (immunocytokines) with improved biological properties and adaptable cytokine activity
Stephen D. Gillies
PROTEIN ENGINEERING DESIGN & SELECTION (2013)
Particle-mediated delivery of cytokines for immunotherapy
David A. Christian et al.
IMMUNOTHERAPY (2012)
Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy
Jason Park et al.
NATURE MATERIALS (2012)
US Food and Drug Administration Approval: Peginterferon-alfa-2b for the Adjuvant Treatment of Patients with Melanoma
Thomas M. Herndon et al.
ONCOLOGIST (2012)
Development of sipuleucel-T: Autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer
Robert B. Sims
VACCINE (2012)
Cytokine-neuroantigen fusion proteins as a new class of tolerogenic, therapeutic vaccines for treatment of inflammatory demyelinating disease in rodent models of multiple sclerosis
Mark D. Mannie et al.
FRONTIERS IN IMMUNOLOGY (2012)
Dimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapy
Raquel Mejias et al.
BIOMATERIALS (2011)
Autoimmunity associated with immunotherapy of cancer
Sally M. Amos et al.
BLOOD (2011)
A Phase 1 Study of AS1409, a Novel Antibody-Cytokine Fusion Protein, in Patients with Malignant Melanoma or Renal Cell Carcinoma
Sarah M. Rudman et al.
CLINICAL CANCER RESEARCH (2011)
A Low-Toxicity IL-2-Based Immunocytokine Retains Antitumor Activity Despite Its High Degree of IL-2 Receptor Selectivity
Stephen D. Gillies et al.
CLINICAL CANCER RESEARCH (2011)
GM-CSF-Based Fusion Cytokines as Ligands for Immune Modulation
Patrick Williams et al.
JOURNAL OF IMMUNOLOGY (2011)
Chronic Chemoimmunotherapy Achieves Cure of Spontaneous Murine Mammary Tumors via Persistent Blockade of Posttherapy Counter-Regulation
Rachael B. Rowswell-Turner et al.
JOURNAL OF IMMUNOLOGY (2011)
Controlled release recombinant human interferon-α2b for treating patients with chronic hepatitis C genotype 1: a phase 2a clinical trial
I. Dzyublyk et al.
JOURNAL OF VIRAL HEPATITIS (2011)
PEGylation of therapeutic proteins
Simona Jevsevar et al.
BIOTECHNOLOGY JOURNAL (2010)
Why Do We Need Another Interferon?
Paul J. Pockros
GASTROENTEROLOGY (2010)
Advances in viral-vector systemic cytokine gene therapy against cancer
Lihua Liu et al.
VACCINE (2010)
The colony-stimulating factors and cancer
Donald Metcalf
NATURE REVIEWS CANCER (2010)
Effector and regulatory B cells: modulators of CD4+ T cell immunity
Frances E. Lund et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors
Yuki Hori et al.
ACTA BIOMATERIALIA (2009)
Engulfing tumors with synthetic extracellular matrices for cancer immunotherapy
Yuki Hor et al.
BIOMATERIALS (2009)
Current status and challenges of cytokine pharmacology
Z. Zidek et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
The High-Dose Aldesleukin (IL-2) Select Trial: A Trial Designed to Prospectively Validate Predictive Models of Response to High-Dose IL-2 Treatment in Patients With Metastatic Renal Cell Carcinoma
Jessica M. Clement et al.
CLINICAL GENITOURINARY CANCER (2009)
Albinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic hepatitis C
Vinod K. Rustgi
CURRENT MEDICAL RESEARCH AND OPINION (2009)
PEG-modified biopharmaceuticals
Pascal Bailon et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma: A Phase III Randomized Controlled Trial of Health-Related Quality of Life and Symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group
Andrew Bottomley et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Interleukin-2: Evaluation of Routes of Administration and Current Delivery Systems in Cancer Therapy
Mohamed A. Shaker et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Infection-mimicking materials to program dendritic cells in situ
Omar A. Ali et al.
NATURE MATERIALS (2009)
Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy
Yuki Hori et al.
BIOMATERIALS (2008)
Many cytokines are very useful therapeutic targets in disease
Marc Feldmann
JOURNAL OF CLINICAL INVESTIGATION (2008)
Growth factors and cytokines in wound healing
Stephan Barrientos et al.
WOUND REPAIR AND REGENERATION (2008)
How regulatory T cells work
Dario A. A. Vignali et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Historical insights into cytokines
Charles A. Dinarello
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Erythropoietin in cancer: Presumption of innocence?
C. Anthony Blau
STEM CELLS (2007)
Cytokines, Inflammation, and Pain
Jun-Ming Zhang et al.
INTERNATIONAL ANESTHESIOLOGY CLINICS (2007)
Ambient occlusion and edge cueing to enhance real time molecular visualization
Marco Tarini et al.
IEEE TRANSACTIONS ON VISUALIZATION AND COMPUTER GRAPHICS (2006)
TNF-α in cancer treatment:: Molecular insights, antitumor effects, and clinical utility
Remco van Horssen et al.
ONCOLOGIST (2006)
Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers
MR Dreher et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Novel nonviral delivery approaches for interleukin-12 protein and gene systems: Curbing toxicity and enhancing adjuvant activity
Mohamed Labib Salem et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2006)
Constitutive expression of IL-2Rbeta chain and its effects on IL-2-induced vascular leak syndrome
E Assier et al.
CYTOKINE (2005)
Side effects of interferon-α therapy
S Sleijfer et al.
PHARMACY WORLD & SCIENCE (2005)
Historical review: Cytokines as therapeutics and targets of therapeutics
J Vilcek et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Of mice and not men: Differences between mouse and human immunology
J Mestas et al.
JOURNAL OF IMMUNOLOGY (2004)
Intratumoral IL-12 and TNF-α-loaded microspheres lead to regression of breast cancer and systemic antitumor immunity
MS Sabel et al.
ANNALS OF SURGICAL ONCOLOGY (2004)
Human neutrophils produce interferon gamma upon stimulation by interleukin-12
F Ethuin et al.
LABORATORY INVESTIGATION (2004)
Interferons, interferon-like cytokines, and their receptors
S Pestka et al.
IMMUNOLOGICAL REVIEWS (2004)
Human cancer gene therapy with cytokine gene-modified cells
PJ Wysocki et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Interleukin-10 therapy - Review of a new approach
K Asadullah et al.
PHARMACOLOGICAL REVIEWS (2003)
Implantable, polymeric systems for modulated drug delivery
S Sershen et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Use of peginterferon a1fa-2a (40 KD) (Pegasys®) for the treatment of hepatitis C
KR Reddy et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Clinical applications of colony-stimulating factors: A historical perspective
RK Sylvester
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2002)
Interleukin-2 liposomes for primary immune deficiency using the aerosol route
RM Ten et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2002)
Intratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug delivery
EP Goldberg et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2002)
Interleukin-2-induced small unilamellar vesicle coalescence
LT Boni et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
Pegylated cytokines - Potential application in immunotherapy of cancer
JF Eliason
BIODRUGS (2001)
Peginterferon alfa-2a in patients with chronic hepatitis C
S Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Inhalational interleukin-2 liposomes for pulmonary metastases: a phase I clinical trial
KM Skubitz et al.
ANTI-CANCER DRUGS (2000)
Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients
N Haicheur et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
分享论文
